Thrombocytopenia in Pregnancy: Clinical Challenges, Maternal–Fetal Risks, and Management Strategies
Life · 12.03.2026 · 16 (3) · 462
DOI: 10.3390/life16030462 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Life, online erschienen am 12.03.2026. Verfasst von Sofoklis Stavros und 12 weiteren Autor:innen. Beteiligte Einrichtung: Third Department of Obstetrics and Gynecology, University General Hospital "ATTIKON", Medical School, National and Kapodistrian University of Athens,…. Die Arbeit nennt 136 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Thrombocytopenia affects up to 10% of pregnant women and represents the second most common blood disorder during pregnancy. Its causes include immune-mediated thrombocytopenia, hemolysis, elevated liver enzymes and low platelet count (HELLP) syndrome, preeclampsia (PE), and benign pregnant thrombocytopenia. Diagnosis is crucial because the cause dictates the effect on maternal health, pregnancy management, and neonatal outcomes. This narrative review examines the range of thrombocytopenia during pregnancy, primarily focusing on diagnostic evaluation, underlying pathophysiological causes, and differential diagnosis. In addition, it organizes maternal and fetal complications that might be caused by the condition, such as bleeding, preterm birth, and neonatal thrombocytopenia. Moreover, current patient management based on available evidence and clinical practice is discussed, including immunomodulatory therapies, platelet transfusions, clinical monitoring, and supportive care. A thorough and clinically guided approach to thrombocytopenia in pregnancy is indispensable for maximizing maternal and fetal outcomes and facilitating the personalization of perinatal care.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Third Department of Obstetrics and Gynecology, University General Hospital "ATTIKON", Medical School, National and Kapodistrian University of Athens, 12462 Athens, Greece.
- First Department of Obstetrics and Gynecology, Alexandra Hospital, Medical School, National and Kapodistrian University of Athens, 11528 Athens, Greece.
- Unit of Maternal-Fetal-Medicine, Department of Obstetrics and Gynecology, Medical School, Democritus University of Thrace, 68100 Alexandroupolis, Greece.
- Department of Nursing, School of Health Sciences, University of Ioannina, 45500 Ioannina, Greece.
- Obstetrics and Gynecology, Royal Cornwall Hospital, Truro TR1 3LJ, UK.
- Department of Obstetrics and Gynecology, Tzanio Hospital, 18536 Piraeus, Greece.
ORCID-Profile: Angeliki Gerede, Themos Grigoriadis, Efthalia Moustakli, Athanasios Zikopoulos, Dimos Sioutis, Konstantinos Louis, Anastasios Potiris
Zitieren
APA
Stavros, S., Kathopoulis, N., Gerede, A., Grigoriadis, T., Moustakli, E., Zikopoulos, A., Arkouli, N., Machairoudias, P., Tzeli, M., Anagnostaki, I., Sioutis, D., Louis, K., & Potiris, A. (2026). Thrombocytopenia in Pregnancy: Clinical Challenges, Maternal–Fetal Risks, and Management Strategies. Life, 16(3), 462. https://doi.org/10.3390/life16030462
Vancouver
Stavros S, Kathopoulis N, Gerede A, Grigoriadis T, Moustakli E, Zikopoulos A, et al. Thrombocytopenia in Pregnancy: Clinical Challenges, Maternal–Fetal Risks, and Management Strategies. Life. 2026;16(3):462. doi:10.3390/life16030462
BibTeX
@article{Stavros2026,
author = {Stavros, Sofoklis and Kathopoulis, Nikolaos and Gerede, Angeliki and Grigoriadis, Themos and Moustakli, Efthalia and Zikopoulos, Athanasios and Arkouli, Nefeli and Machairoudias, Pavlos and Tzeli, Maria and Anagnostaki, Ismini and Sioutis, Dimos and Louis, Konstantinos and Potiris, Anastasios},
title = {Thrombocytopenia in Pregnancy: Clinical Challenges, Maternal–Fetal Risks, and Management Strategies},
journal = {Life},
year = {2026},
volume = {16},
number = {3},
pages = {462},
doi = {10.3390/life16030462}
}
EUVIMED